Merck's Keytruda Qlex offers a groundbreaking subcutaneous cancer treatment, enhancing patient convenience with faster ...
Portal Access, an oncology-focused medical device startup, closed a $7 million Series A financing round. The company said that more than 80% of the round was led by U.S. physician investors, including ...
The FDA has approved Keytruda Qlex, a faster, under-the-skin cancer treatment offering convenience and flexibility. Here's ...
The LifeSite Hemodialysis System (Vasca, Inc., Tewksbury, MA, USA)is totally subcutaneous, incorporating two silicone catheters positioned in the central venous system and connected to a stainless ...
The LifeSite subcutaneous access system allows immediate hemodialysis after implantation. The device consists of a silicone cannula, which is placed in a central venous location (usually via the right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback